Humatin dose and Humatin uses

	Post Humatin Side Effect Reporting Your Humatin side effect will help others recognize and deal with Humatin side effects.
	Recent Reports View Humatin reports recently posted by other patients.
	FDA Humatin Reports Read Humatin adverse events reported to FDA.

What was Your Humatin Experience? Share with others:

HUMATIN - paromomycin sulfate capsule 
Monarch Pharmaceuticals, Inc.

----------

Humatin®
(Paromomycin Sulfate Capsules, USP)

Description

Humatin is a broad spectrum antibiotic produced by Streptomyces rimosus var. paromomycinus. It is a white, amorphous, stable, water-soluble product supplied as capsules containing the equivalent of 250 mg paromomycin.

The capsule contains D&C yellow No. 10; FD&C blue No. 1; FD&C red No. 3; FD&C yellow No. 6; gelatin, NF; and titanium dioxide, USP.

Action

The in vitro and in vivo antibacterial action of paromomycin closely parallels that of neomycin. It is poorly absorbed after oral administration, with almost 100% of the drug recoverable in the stool.

Indications

Humatin is indicated for intestinal amebiasis––acute and chronic (NOTE ––It is not effective in extraintestinal amebiasis); management of hepatic coma––as adjunctive therapy.

Contraindications

Paromomycin sulfate is contraindicated in individuals with a history of previous hypersensitivity reactions to it. It is also contraindicated in intestinal obstruction.

Precautions

The use of this antibiotic, as with other antibiotics, may result in an overgrowth of nonsusceptible organisms, including fungi. Constant observation of the patient is essential. If new infections caused by nonsusceptible organisms appear during therapy, appropriate measures should be taken.

The drug should be used with caution in individuals with ulcerative lesions of the bowel to avoid renal toxicity through inadvertent absorption.

Pediatric Use: See Dosage and Administration section.

Adverse Reactions

Nausea, abdominal cramps, and diarrhea have been reported in patients on doses over 3 g daily.

Dosage and Administration

Intestinal amebiasis: Adults and Pediatric Patients: Usual dose––25 to 35 mg/kg body weight daily, administered in three doses with meals, for five to ten days.

Management of hepatic coma: Adults: Usual dose––4 g daily in divided doses, given at regular intervals for five to six days.

How Supplied

Humatin Capsules, each containing paromomycin sulfate equivalent to 250 mg paromomycin, are supplied as follows

NDC 61570-529-10: Bottles of 100

Store at controlled room temperature 15°â€“30°C (59°â€“86°F).

Protect from moisture.

Rx only.

Prescribing Information as of November 2001.

Distributed by: Monarch Pharmaceuticals, Inc., Bristol, TN 37620

Manufactured by: Caraco Pharmaceutical Laboratories, Ltd., Detroit, MI 48202

HUMATIN  paromomycin sulfate  capsule

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 61570-529 Route of Administration ORAL DEA Schedule

INGREDIENTS Name (Active Moiety) Type Strength Paromomycin Sulfate (Paromomycin) Active 250 MILLIGRAM  In 1 CAPSULE D&C yellow No. 10 Inactive   FD&C blue No. 1 Inactive   FD&C red No. 3 Inactive   FD&C yellow No. 6 Inactive   gelatin Inactive   titanium dioxide Inactive

Product Characteristics Color YELLOW Score no score Shape CAPSULE Size 19mm Flavor Imprint Code Contains      Coating false Symbol false

Packaging # NDC Package Description Multilevel Packaging 1 61570-529-10 100 CAPSULE In 1 BOTTLE None

Revised: 03/2007Monarch Pharmaceuticals, Inc.